Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2021-11-25 | 2022-01-07 | 149937 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-11-25 | 2021-12-23 | 149945 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-12-02 | 2023-01-26 | 150409 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-12-17 | 2022-12-02 | 151381 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151419 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2021-12-17 | 2022-05-26 | 151433 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
| TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-12-17 | 2024-05-30 | 151465 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-12-17 | 2021-12-23 | 151471 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-01-07 | 2022-03-09 | 152408 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152411 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152414 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-01-07 | 2022-08-19 | 152417 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153144 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2022-01-20 | 2022-02-25 | 153159 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153162 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |